CHARBON ACTIF 230 MG
CHARCOAL ACTIVATED : 230 MG · DIN 02398281 · NATURAL WORLD DISTRIBUTION INC
Health Canada status: CANCELLED PRE MARKET
What is CHARBON ACTIF?
CHARBON ACTIF 230 MG contains CHARCOAL ACTIVATED : 230 MG. It is listed in the Health Canada Drug Product Database under DIN 02398281, held by NATURAL WORLD DISTRIBUTION INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled pre market, status dated 08-Sep-2017. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02398281 |
|---|---|
| Brand name | CHARBON ACTIF |
| Generic / active ingredient | CHARCOAL ACTIVATED : 230 MG |
| Manufacturer | NATURAL WORLD DISTRIBUTION INC |
| Strength | 230 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | A07BA01 MEDICINAL CHARCOAL |
| AHFS class | 56:10.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED PRE MARKET |
| Status date | 08-Sep-2017 |
What can be used instead?
Other Canadian products sharing ATC code A07BA01 MEDICINAL CHARCOAL. 10 of 29 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ACTIVATED CHARCOAL | 225 MG | CAPSULE | JAMP PHARMA CORPORATION | MARKETED | DIN 02420694 |
| ACTIVATED CHARCOAL | 225 MG | CAPSULE | LABORATOIRE LEO DESILETS M.H. INC | MARKETED | DIN 02236563 |
| ACTIVATED CHARCOAL 260MG | 260 MG | CAPSULE | EXZELL PHARMA INC | MARKETED | DIN 00789674 |
| ACTIVATED CHARCOAL CAPSULES | 250 MG | CAPSULE | NATURAL FACTORS NUTRITIONAL PRODUCTS LTD. | MARKETED | DIN 02504723 |
| ACTIVATED CHARCOAL CAPSULES | 250 MG | CAPSULE | BIOCLINIC NATURALS INC. | MARKETED | DIN 02537680 |
| CHARAC-25 | 222 MG | SUSPENSION | OMEGA LABORATORIES LIMITED | MARKETED | DIN 02056429 |
| CHARAC-50 | 50 G / 225 ML | SUSPENSION | OMEGA LABORATORIES LIMITED | MARKETED | DIN 00637955 |
| CHARACTOL-50 | 50 G / 250 ML | SUSPENSION | OMEGA LABORATORIES LIMITED | MARKETED | DIN 00649236 |
| CHARCO CAPS | 260 MG | CAPSULE | DSE HEALTHCARE SOLUTIONS LLC | MARKETED | DIN 02423715 |
| WAMPOLE ACTIVATED CHARCOAL | 225 MG | CAPSULE | JAMP PHARMA CORPORATION | MARKETED | DIN 02395517 |
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled pre market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.